betahistine has been researched along with Dizziness in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 6 (31.58) | 2.80 |
| Authors | Studies |
|---|---|
| Hui, J; Ji, Z; Lei, Q; Zi, D | 1 |
| Erdur, ZB; Evran, N | 1 |
| Gerami, H; Jalali, MM; Razaghi, S; Saberi, A | 1 |
| Chen, XB; Liu, JG; Liu, JL; Liu, YH | 1 |
| Li, HW; Liu, JP; Wang, WQ; Wu, PX | 1 |
| Amelin, AV; Guseva, AL; Kunelskaya, NL; Lilenko, SV; Lyapin, AV; Melnikov, OA; Samartcev, IN; Voronov, VA; Zamergrad, MV; Zaytseva, OV | 1 |
| Cao, W; Hu, Y; Li, H; Wu, P | 1 |
| Beyea, JA; Beyea, MM; Simpson, MTW; Sykes, EA; Wu, V | 1 |
| Desai, PB; Gabbita, P; Moorthy, G; Sallans, L; Sallee, F; Zemlan, F | 1 |
| Lilenko, SV; Melnikov, OA; Nauta, J; Ouwens, MJ | 1 |
| Acar, B; Buran, Y; Karasen, RM | 1 |
| Duma, SN; Shcherbakova, LV | 1 |
| Maarsingh, OR; Schellevis, FG; van der Horst, HE | 1 |
| Holovchenko, IuI; Kozlova, OO; Slobodin, TM; Trinus, KF; Vasyl'chuk, IS | 1 |
| Datcov, E; Petrova, D; Sachansca, T | 1 |
| Kovalenko, AP; Odinak, MM | 1 |
| Jurkiewicz, D; Kantor, I; Usowski, J | 1 |
| Thömke, F | 1 |
| Curley, JW | 1 |
3 review(s) available for betahistine and Dizziness
| Article | Year |
|---|---|
[Betahistine in vestibular disorders: current concepts and perspectives].
Topics: Benign Paroxysmal Positional Vertigo; Betahistine; Dizziness; Humans; Meniere Disease; Vestibular Diseases | 2021 |
Approach to Ménière disease management.
Topics: Betahistine; Diet, Sodium-Restricted; Disease Management; Diuretics; Dizziness; Female; Hearing Loss, Sensorineural; Humans; Meniere Disease; Middle Aged; Tinnitus; Vertigo | 2019 |
[Frequently occurring forms of dizziness and their treatment].
Topics: Amines; Anticonvulsants; Betahistine; Carbamazepine; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Dizziness; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Magnetic Resonance Imaging; Memantine; Meniere Disease; Middle Aged; Migraine Disorders; Nystagmus, Physiologic; Syndrome; Time Factors; Vasodilator Agents; Vertigo; Vestibular Diseases; Vestibular Neuronitis | 2007 |
6 trial(s) available for betahistine and Dizziness
| Article | Year |
|---|---|
[Intervention strategies for residual dizziness after successful repositioning maneuvers in benign paroxysmal positional vertigo: a single center randomized controlled trial].
Topics: Benign Paroxysmal Positional Vertigo; Betahistine; Dizziness; Humans; Patient Positioning; Vestibule, Labyrinth | 2021 |
Effects of vestibular rehabilitation, with or without betahistine, on managing residual dizziness after successful repositioning manoeuvres in patients with benign paroxysmal positional vertigo: a protocol for a randomised controlled trial.
Topics: Adult; Aged; Benign Paroxysmal Positional Vertigo; Betahistine; Dizziness; Female; Humans; Male; Middle Aged; Patient Positioning; Physical Therapy Modalities; Practice Guidelines as Topic; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents; Vestibule, Labyrinth | 2019 |
Safety, tolerability and pharmacokinetics of 2-pyridylacetic acid, a major metabolite of betahistine, in a phase 1 dose escalation study in subjects with ADHD.
Topics: Acetates; Administration, Oral; Adult; Attention Deficit Disorder with Hyperactivity; Betahistine; Dizziness; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Psychomotor Agitation; Pyridines; Single-Blind Method; Young Adult | 2015 |
Efficacy of medical therapy in the prevention of residual dizziness after successful repositioning maneuvers for Benign Paroxysmal Positional Vertigo (BPPV).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benign Paroxysmal Positional Vertigo; Betahistine; Child; Combined Modality Therapy; Dizziness; Female; Ginkgo biloba; Humans; Male; Middle Aged; Patient Positioning; Phytotherapy; Plant Extracts; Treatment Outcome; Trimetazidine; Vasodilator Agents; Young Adult | 2015 |
[Diagnosis and treatment of psychogenic dizziness in patients with arterial hypertension].
Topics: Aged; Anxiety; Asthenia; Betahistine; Dizziness; Female; gamma-Aminobutyric Acid; Humans; Hypertension; Male; Treatment Outcome | 2016 |
[Betaserk in the treatment of aftereffects of craniocerebral injury and vascular events].
Topics: Acute Disease; Adult; Betahistine; Brain; Brain Injuries; Brain Ischemia; Cerebrovascular Circulation; Dizziness; Drug Administration Schedule; Female; Headache; Histamine Agonists; Humans; Male; Middle Aged; Treatment Outcome; Vasodilator Agents | 2005 |
10 other study(ies) available for betahistine and Dizziness
| Article | Year |
|---|---|
Betahistine alleviates benign paroxysmal positional vertigo (BPPV) through inducing production of multiple CTRP family members and activating the ERK1/2-AKT/PPARy pathway.
Topics: Animals; Benign Paroxysmal Positional Vertigo; Betahistine; Dizziness; Humans; MAP Kinase Signaling System; Mice; PPAR gamma; Proto-Oncogene Proteins c-akt | 2022 |
Effect of betahistine treatment on dizziness and anxiety symptoms of BPPV patients.
Topics: Benign Paroxysmal Positional Vertigo; Betahistine; Dizziness; Humans; Quality of Life; Treatment Outcome | 2023 |
The Impact of Betahistine versus Dimenhydrinate in the Resolution of Residual Dizziness in Patients with Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial.
Topics: Adolescent; Adult; Aged; Benign Paroxysmal Positional Vertigo; Betahistine; Dimenhydrinate; Dizziness; Double-Blind Method; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vasodilator Agents; Young Adult | 2020 |
The benefits of betahistine or vestibular rehabilitation (Tetrax biofeedback) on the quality of life and fall risk in patients with Ménière's disease.
Topics: Accidental Falls; Adult; Aged; Betahistine; Biofeedback, Psychology; Case-Control Studies; Combined Modality Therapy; Dizziness; Female; Histamine Agonists; Humans; Male; Meniere Disease; Middle Aged; Quality of Life; Rehabilitation; Risk Assessment; Treatment Outcome; Vestibule, Labyrinth | 2020 |
Betahistine plus piracetam dual therapy versus betahistine monotherapy for peripheral vestibular vertigo: a confounder-corrected subanalysis of the OSVaLD study.
Topics: Adult; Aged; Betahistine; Dizziness; Female; Humans; Male; Middle Aged; Odds Ratio; Piracetam; Vasodilator Agents; Vertigo | 2015 |
Looks vestibular: irrational prescribing of antivertiginous drugs for older dizzy patients in general practice.
Topics: Aged; Aged, 80 and over; Betahistine; Cinnarizine; Dizziness; Female; General Practice; Histamine Antagonists; Humans; Male; Practice Patterns, Physicians'; Regression Analysis | 2012 |
[Vertigo: patient management tactics].
Topics: Adult; Betahistine; Diagnosis, Differential; Dizziness; Female; Histamine Agonists; Humans; Male; Treatment Outcome; Vertigo; Vestibular Neuronitis; Young Adult | 2012 |
Investigation of Betaserc in auditory and vestibular disturbances.
Topics: Adult; Audiometry; Auditory Diseases, Central; Auditory Pathways; Betahistine; Dizziness; Electronystagmography; Humans; Male; Nystagmus, Pathologic; Treatment Outcome; Vasodilator Agents; Vertigo; Vestibule, Labyrinth | 2004 |
[Assessment of betahistine dihydrochloride effectiveness in the treatment of disturbance of balance system, based on analysis of doctors and patients questionnaires results].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Betahistine; Data Collection; Dizziness; Female; Hearing Loss; Humans; Male; Middle Aged; Patient Satisfaction; Product Surveillance, Postmarketing; Quality of Life; Surveys and Questionnaires; Tinnitus; Treatment Outcome; Vertigo; Vomiting | 2006 |
The treatment of peripheral dizziness.
Topics: Antiemetics; Betahistine; Dizziness; Endolymphatic Sac; Humans; Labyrinth Diseases; Meniere Disease; Parasympatholytics; Phenothiazines; Sympathectomy; Ultrasonic Therapy; Vasodilator Agents | 1984 |